Docemo
RIZIV-accredited1 hour/pointPhysical exerciseRIZIV 26011233

Physical activity as a key to well-being: cancer

Start the e-learning

RIZIV recognition number: 26011233

The medical approach to cancer often focuses on diagnosis and treatment. However, there is a need for more attention to factors that influence the course of the disease and the quality of life of the patient. This training clarifies the role that physical activity can play at every stage: from preventive advice to support during and after therapy. 

You will gain insight into the impact of exercise on the mortality risk in breast cancer, colorectal cancer, lung cancer, and prostate cancer. Additionally, you will learn why physical inactivity remains an important concern for survivors of the disease. The course provides clear guidelines for exercise for patients and survivors, with attention to the preventive effects. 

Next, it will be explained how physical activity can be safely integrated during treatments such as chemotherapy, radiotherapy, and hormone therapy. You will receive an overview of the recommendations per stage, including diagnosis, active treatment, and advanced disease. Finally, the training summarizes the key insights and provides you with clinical tips.

This training makes you as a general practitioner a stronger link in the quality of life and long-term care of your patient with cancer.

What will you learn?

Impact van inactiviteit bij kankerpatiënten en overlevenden
Effect van lichaamsbeweging op sterfterisico bij borst-, darm-, long- en prostaatkanker
Bewegingsrichtlijnen voor kankerpatiënten en overlevenden
Preventieve effecten van fysieke activiteit op kanker
Veilig bewegen tijdens chemo-, radio- en hormoontherapie
Aanbevelingen per fase: preventie, diagnose, behandeling en nazorg

Content

1. Belang van lichaamsbeweging bij kanker7 min
2. Borstkanker en darmkanker7 min
3. Longkanker en prostaatkanker7 min
4. Richtlijnen en preventieve effecten8 min
5. Kanker en sterfte door lichamelijke inactiviteit6 min
6. Bewegen tijdens de behandeling6 min
7. Veiligheidsrichtlijnen tijdens de behandeling6 min
8. Aanbevelingen per fase van de ziekte8 min
9. Belangrijkste punten en klinische tips3 min
10. Conclusie2 min
Also available in